<?xml version="1.0" encoding="UTF-8"?>
<p>Although the variable ‘criteria’ explained the increase in costs in GLM analyses (p&lt;0.001), other variables, such as dengue classification, age, type of hospitalisation, and side effects, also contributed to increased costs. Therefore, the absence of WHO criteria for the use of blood components contributes to increased costs; however, this factor does not completely account for increased costs. The mean length of stay was similar to that in other studies performed with patients hospitalised due to dengue in Brazil [
 <xref rid="pone.0219287.ref012" ref-type="bibr">12</xref>, 
 <xref rid="pone.0219287.ref015" ref-type="bibr">15</xref>, 
 <xref rid="pone.0219287.ref048" ref-type="bibr">48</xref>].
</p>
